Showing 1 - 10 of 36,324
-based resources could reduce the requirement for hospitalisation, thereby reducing the total direct healthcare costs. …
Persistent link: https://www.econbiz.de/10005448841
consumption are recalled to the same degree: medication use tends to be recalled with less accuracy than hospitalisation. In terms …
Persistent link: https://www.econbiz.de/10005448987
Objective: The aim of the study was to measure the use and estimate the cost of HIV service provision in England. Design and Setting: Standardised activity and case-severity data were collected prospectively in 10 English HIV clinics (5 London and 5 non-London sites) for the periods 1 January...
Persistent link: https://www.econbiz.de/10005449215
Objective: To assess the relationship between severity and progression of illness in Parkinson's disease and the use of healthcare resources. Design and setting: This was a prospective cost-of-illness study conducted in France based on clinical observation over a 6-month period of patients with...
Persistent link: https://www.econbiz.de/10005590382
Objective: The first aim was to identify and determine the economic costs of the regimens currently used in 3 New Zealand hospitals in the treatment of bacterial infections in haematology patients with febrile neutropenia and in intensive care patients with severe infections. The second was to...
Persistent link: https://www.econbiz.de/10005590387
Objective: Osteoporosis-related costs are now considered a major burden for health authorities in most developed countries. An accurate and exhaustive evaluation of these costs would be a major contribution to health economic studies evaluating the efficiency of screening and prevention...
Persistent link: https://www.econbiz.de/10005590407
schizophrenia and requiring a hospitalisation in the calendar year 1988 or 1992, by primary payer type (Medicare; Medicaid; or …
Persistent link: https://www.econbiz.de/10005590212
Objective: To determine the cost effectiveness of enoxaparin therapy versus unfractionated heparin (UFH) therapy for patients with unstable coronary artery disease from the perspective of a Canadian hospital. Design: A predictive decision analysis model using published clinical and economic...
Persistent link: https://www.econbiz.de/10005590291
Background: Hyperphosphatemia is very common in patients with end-stage renal disease (ESRD). Recently, a new phosphate binder, sevelamer, has become available in the US to treat this condition. The high cost of sevelamer has significantly impacted on third-party payors such as Florida Medicaid....
Persistent link: https://www.econbiz.de/10005448803
Objective: The purpose of this study was to compare, from the payor perspective, the clinical and economic outcomes of olanzapine to those of haloperidol for the treatment of schizophrenia. Design and setting: Clinical, quality-of-life and resource utilisation data were prospectively collected...
Persistent link: https://www.econbiz.de/10005449144